Mycophenolate mofetil in nonlupus glomerulonephropathy

Lupus

Volumn 14, Issue SUPPL. 1, 2005, Pages

  Karim, M Y ^a,b   Abbs, I C ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

FSGS; Glomerulopathy; IgA nephropathy; Membranoproliferative; Membranous; Mesangiocapillary; Mycophenolate

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; CLINICAL TRIAL; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; GOODPASTURE SYNDROME; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOLOGY; IMMUNOPROPHYLAXIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 16244398657     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120330501400108     Document Type: Article

References (19)

1. Warrens AN. The evolving role of mycophenolate mofetil in renal transplantation. QJM 2000; 93: 15-20.
2. Ginzler EM, Aranow C, Buyon J et al. Multicenter study of mycophenolate mofetil (MMF) vs. intravenous cyclophosphamide (IVC) as induction therapy for severe lupus nephritis (LN): preliminary results. (Abstract) American College of Rheumatology Meeting, October 2003, Orlando.
3. Dooley MA, Cosio FG, Nachman PH et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999; 10; 833-839.
4. Maes BD, Oyen R, Claes K et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004; 65: 1842-1849.
5. Choi MJ, Eustace JA, Gimenez LF et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002; 61: 1098-1114.
6. Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant 2004; 19: 3160-3164.
7. Reed MJ, Alexander GJ, Thiru S, Smith KG. Hepatitis C-associated glomerulonephritis-a novel therapeutic approach. Nephrol Dial Transplant 2001; 16: 869-871.
8. Garcia-Canton C, Toledo A, Palomar R et al. Goodpasture's syndrome treated with mycophenolate mofetil. Nephrol Dial Transplant 2000; 15: 920-922.
9. Adu D, Cross J, Jayne DR. Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus 2001; 10: 203-208.
10. Penny MJ, Boyd RA, Hall BM. Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol 1998; 9: 2272-2282.
11. Dubus I, Vendrely B, Christophe I et al. Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int 2002; 62: 857-867.
12. Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 1999; 14: 58-63.
13. Yu CC, Yang CW, Wu MS et al. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomeralosclerosis in MRL/lpr mice. J Lab Clin Med 2001; 138: 69-77.
14. Badid C, Vincent M, McGregor B et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000; 58: 51-61.
15. Bergner R, Hoffmann M, Brass H, Uppenkamp M. Therapy of IgA nephropathy with mycophenolate mofetil-report of 3 cases. Clin Nephrol 2004; 61: 207-212.
16. Hogg RJ, Wyatt RJ. Scientific Planning Committee of the North American IgA Nephropathy Study. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN6257616]. BMC Nephrol 2004; 5: 3.
17. Miller G, Zimmerman R 3rd, Radhakrishnan J, Appel G. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 2000; 36: 250-256.
18. Bagga A, Hari P, Moudgil A, Jordan SC. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 2003; 42: 1114-1120.
19. Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 2004; 19: 101-104.